Latest filing published 20 Mar 2019 for Mirati Therapeutics, Inc., €8.5M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
venBio Select Advisor LLC: trading record in brief
venBio Select Advisor LLC is a declared insider at 2 companies; the most frequent names are Mirati Therapeutics, Inc. and Immunomedics Inc. The record holds 12 filings, for trades running from 14 November 2017 to 20 March 2019.
In open-market terms, that means 6 purchases worth €48.2M on one side and 4 sales worth €60.7M on the other. Sales outweigh purchases by €12.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants. Since January 2019: no purchases and 4 sales on the market.
Half of the purchases are above €8.7M and half below. On 3 out of 6 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 20 March 2019 came the latest disclosure, an open-market sale for €6.5M in Mirati Therapeutics, Inc. The most recent open-market purchase was published on 19 June 2018, 3,065 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to venBio Select Advisor LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 125,000 shares@ US$76.5511.4% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-19-001604:0
- 100,000 shares@ US$73.438.8% of flowCommon StockSEC:0000902664-19-001604:1
- 23,781 shares@ US$72.802.1% of flowCommon StockSEC:0000902664-19-001604:2
- 686,820 shares@ US$73.0059.8% of flowCommon Stock, $0.001 par value per shareSEC:0000902664-19-001248:0
- 200,000 shares@ US$23.3912.4% of flowCommon Stock, $0.01 par value per shareSEC:0000902664-18-002624:0Canonical exit: 13 Sept 2018 (T+90)
- 575,000 shares@ US$24.0036.4% of flowCommon Stock, $0.01 par value per shareSEC:0000902664-18-002593:0Canonical exit: 13 Sept 2018 (T+90)
- 400,000 shares@ US$38.8516.2% of flowCommon Stock, $0.001 par value per share ("Common Stock")SEC:0000902664-18-002549:0Canonical exit: 9 Sept 2018 (T+90)
- 875,000 shares@ US$7.0015.0% of flowCommon Stock, $0.01 par value per share (the "Common Stock")SEC:0000902664-18-001218:0
- 650,000 shares@ US$13.008.8% of flowCommon Stock, $0.001 par value per share (the "Common Stock"SEC:0000902664-17-004377:0Canonical exit: 14 Feb 2018 (T+90)
- 37,500 shares@ US$7.860.3% of flowCommon StockSEC:0000902664-17-004377:1
- 175,000 shares@ US$10.975.0% of flowCommon StockSEC:0000902664-17-004371:1Canonical exit: 13 Feb 2018 (T+90)
- 1,150,000 shares@ US$10.3931.3% of flowCommon Stock, $0.01 par value per share (the "Common Stock")SEC:0000902664-17-004371:0Canonical exit: 12 Feb 2018 (T+90)
12 of 10 declarations
